semaglutide gi obstruction attorney in louisiana michigan glp-1 class action bowel lawyer glp-1 gastric intestinal obstruction in Ozempic GLP-1 Lawsuit & Gastroparesis michigan gastric intestinal obstruction – semaglutide bowel obstruction attorney in

Major acquisitions have created global generic companies with integrated manufacturing, formulation, and regulatory capabilities across multiple markets simultaneously

From 2.4% to 17.6% in Four Years A Truveta analysis of real-world data from January 2021 to September 2025 found that semaglutide or tirzepatide prescribing among women with PCOS rose from 2.4% in 2021 to 17.6% in 2025 more than a seven-fold increase

Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally invasive surgeon Dan Azagury, MD, FACS, explain how these medications work, who may or may not benefit, the potential benefits and risks, and why they're not a one-size-fits-all solution

Fit for any type of skin